Skip to main content

Advertisement

Log in

Hyperparathyroidism–jaw tumor syndrome: a report of three large kindred

  • Current concepts in Endocrine Surgery
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background

Hyperparathyroidism–jaw tumor syndrome (HPT–JT) is a rare autosomal disease caused by inactivating germ-line mutations of HRPT2 gene, with subsequent loss of Parafibromin expression. It is characterized by familial HPT, ossifying jaw tumors, and other associated neoplasms.

Methods

Clinical, histopathological, and genetic features of three large Italian unrelated HPT–JT kindred were assessed.

Results

Three different germ-line HRPT2 inactivating mutations were identified. Seventeen affected members and six healthy mutation carriers were found. HPT was diagnosed in virtually all affected patients, at a median age of 36.3 years (range 11–71). In all cases, a single parathyroid involvement was found at surgery, although a metachronous multiglandular involvement causing recurrence after selective parathyroidectomy occurred in 17.6% of cases, after a mean disease-free interval of 13.7 years (range 5–27). Parathyroid carcinoma, atypical parathyroid adenoma, and jaw tumor occurred in one case; uterine involvement in 61.5% of women; other associated neoplasms were thyroid carcinoma (two cases) and renal and colon carcinoma (one case). Immunohistochemistry confirmed the loss of Parafibromin as the distinctive feature of the disease both in parathyroid and uterine tumors.

Conclusions

HPT–JT has a frequent single-gland parathyroid involvement and a relatively increased risk of parathyroid carcinoma. The penetrance of the disease is high but incomplete. Regardless of the denomination of the syndrome, jaw tumors occur rarely, while uterine involvement is frequently present. Selective parathyroidectomy may be an effective strategy, but a prolonged follow-up is required because of the risk of recurrences and malignancies. A systematic investigation is also required because of associated malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Carling T, Udelsman R (2005) Parathyroid surgery in familial hyperparathyroid disorders. J Intern Med 257:27–37. doi:10.1111/j.1365-2796.2004.01428.x

    Article  PubMed  CAS  Google Scholar 

  2. Cetani F, Pardi E, Borsari SL et al (2004) Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 89:5583–5591. doi:10.1210/jc.2004-0294

    Article  PubMed  CAS  Google Scholar 

  3. Carpten JD, Robbins CM, Villablanca A et al (2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676–680. doi:10.1038/ng1048

    Article  PubMed  CAS  Google Scholar 

  4. Bradley KJ, Hobbs MR, Buley ID et al (2005) Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. J Intern Med 257:18–26. doi:10.1111/j.1365-2796.2004.01421.x

    Article  PubMed  CAS  Google Scholar 

  5. Jackson CE, Norum RA, Boyd SB et al (1990) Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery 108:1006–1012

    PubMed  CAS  Google Scholar 

  6. Shattuck TM, Valimaki S, Obara T et al (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349:1722–1729. doi:10.1056/NEJMoa031237

    Article  PubMed  CAS  Google Scholar 

  7. Porzionato A, Macchi V, Barzon L et al (2006) Immunohistochemical assessment of parafibromin in mouse and human tissues. J Anat 209:817–827. doi:10.1111/j.1469-7580.2006.00657.x

    Article  PubMed  CAS  Google Scholar 

  8. Gill AJ, Clarkson A, Gimm O et al (2006) Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT–JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol 30:1140–1149. doi:10.1097/01.pas.0000209827.39477.4f

    PubMed  Google Scholar 

  9. Juhlin C, Larsson C, Yakoleva T et al (2006) Loss of parafibromin expression in a subset of parathyroid adenomas. Endocr-Relat Cancer 13:509–523. doi:10.1677/erc.1.01058

    Article  PubMed  CAS  Google Scholar 

  10. Bradley KJ, Cavaco BM, Bowl MR et al (2006) Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours. Clin Endocrinol (Oxf) 64:299–306. doi:10.1111/j.1365-2265.2006.02460.x

    Article  CAS  Google Scholar 

  11. Iacobone M, Barzon L, Porzionato A et al (2007) Parafibromin expression, single-gland involvement and limited parathyroidectomy in familial isolated hyperparathyroidism. Surgery 142:984–991. doi:10.1016/j.surg.2007.09.029

    Article  PubMed  Google Scholar 

  12. Masi G, Barzon L, Iacobone M et al (2008) Clinical, genetic, and histopathologic investigation of CDC73-related familial hyperparathyroidism. Endocr-Relat Cancer 15:1115–1126. doi:10.1677/ERC-08-0066

    Article  PubMed  CAS  Google Scholar 

  13. DeLellis RA, Lloyd RV, Heitz PU, Heng C (2004) World Health Organization Classification of Tumours Pathology and Genetics: tumours of endocrine organs. IARC, Lyon

    Google Scholar 

  14. Iacobone M, Lumachi F, Favia G (2004) Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases. J Surg Oncol 88:223–228. doi:10.1002/jso.20152

    Article  PubMed  Google Scholar 

  15. Iacobone M, Ruffolo C, Lumachi F, Favia G (2005) Results of iterative surgery for persistent and recurrent parathyroid carcinoma. Langenbecks Arch Surg 390:385–390. doi:10.1007/s00423-005-0555-6

    Article  PubMed  Google Scholar 

  16. Sarquis MS, Silveira LG, Pimenta FJ et al (2008) Familial hyperparathyroidism: surgical outcome after 30 years of follow up in three families with germline HRPT2 mutations. Surgery 143:630–640. doi:10.1016/j.surg.2007.12.012

    Article  PubMed  Google Scholar 

  17. Howell VM, Haven CJ, Kahnoski K et al (2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. J Med Genet 40:657–663. doi:10.1136/jmg.40.9.657

    Article  PubMed  CAS  Google Scholar 

  18. Simonds WF, Robbins CM, Agarwal SK, Hendy GN, Carpten JD, Marx SJ (2004) Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89:96–102. doi:10.1210/jc.2003-030675

    Article  PubMed  CAS  Google Scholar 

  19. Villablanca A, Calender A, Forsberg L et al (2004) Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). J Med Genet 41:e32. doi:10.1136/jmg.2003.012369

    Article  PubMed  CAS  Google Scholar 

  20. Cavaco BM, Guerra L, Bradley KJ et al (2004) Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene. J Clin Endocrinol Metab 89:1747–1752. doi:10.1210/jc.2003-031016

    Article  PubMed  CAS  Google Scholar 

  21. Howell VM, Zori RT, Stalker HJ et al (2004) A molecular diagnosis of hyperparathyroidism-jaw tumor syndrome in an adolescent with recurrent kidney stones. J Pediatr 145:567. doi:10.1016/j.jpeds.2004.04.023

    Article  PubMed  Google Scholar 

  22. Gimm O, Lorenz K, Nguyen Thanh P et al (2006) Das Familiäre Nebenschilddrüsenkarzinom. Indikation zur prophylaktischen Parathyreoidektomie? Chirurg 77:15–24. doi:10.1007/s00104-005-1110-2

    Article  PubMed  CAS  Google Scholar 

  23. Moon SD, Park JH, Kim EM et al (2005) A novel IVS2–1G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 90:878–883. doi:10.1210/jc.2004-0991

    Article  PubMed  CAS  Google Scholar 

  24. Mizusawa N, Uchino S, Iwata T et al (2006) Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome. Clin Endocrinol (Oxf) 65:9–16. doi:10.1111/j.1365-2265.2006.02534.x

    Article  CAS  Google Scholar 

  25. Aldred MJ, Talacko AA, Savarirayan R et al (2006) Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:212–218. doi:10.1016/j.tripleo.2005.06.011

    Article  PubMed  Google Scholar 

  26. Guarnieri V, Scillitani A, Muscarella LA et al (2006) Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillance. J Clin Endocrinol Metab 91:2827–2832. doi:10.1210/jc.2005-1239

    Article  PubMed  CAS  Google Scholar 

  27. Kelly TG, Shattuck TM, Reyes-Mugica M et al (2006) Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation. J Bone Miner Res 21:1666–1671. doi:10.1359/jbmr.060702

    Article  PubMed  CAS  Google Scholar 

  28. Yamashita Y, Akiyama T, Mizusawa N, Yoshimoto K, Goto M (2007) A case of hyperparathyroidism-jaw tumour syndrome found in the treatment of an ossifying fibroma in the maxillary bone. Int J Oral Maxillofac Surg 36:365–369. doi:10.1016/j.ijom.2006.08.007

    Article  PubMed  CAS  Google Scholar 

  29. Cetani F, Pardi E, Ambrogini E et al (2007) Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation. Endocr-Relat Cancer 14:493–499. doi:10.1677/ERC-06-0092

    Article  PubMed  CAS  Google Scholar 

  30. Cetani F, Ambrogini E, Viacava P et al (2007) Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma? Eur J Endocrinol 156:547–554. doi:10.1530/EJE-06-0720

    Article  PubMed  CAS  Google Scholar 

  31. Raue F, Haag C, Frank-Raue K (2007) Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma. Dtsch Med Wochenschr 132:1459–1462. doi:10.1055/s-2007-982052

    Article  PubMed  CAS  Google Scholar 

  32. Cetani F, Pardi E, Ambrogini E et al (2008) Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment. J Endocrinol Investig 31:900–904

    CAS  Google Scholar 

  33. Guarnieri V, Bisceglia M, Bonfitto N et al (2008) Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Surgery 144:839–840. doi:10.1016/j.surg.2008.08.008

    Article  PubMed  Google Scholar 

  34. Howell VM, Gill A, Clarkson A, Nelson AE et al (2009) Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab 94:434–441. doi:10.1210/jc.2008-1740

    Article  PubMed  CAS  Google Scholar 

  35. Iacobone M, Barzon L, Porzionato A et al (2009) The extent of parathyroidectomy for HRPT2-related hyperparathyroidism. Surgery 145:250–251. doi:10.1016/j.surg.2008.06.027

    Article  PubMed  Google Scholar 

  36. Barry MK, van Heerden JA, Grant CS, Thompson GB, Khosla S (1997) Is familial hyperparathyroidism a unique disease? Surgery 122:1028–1033. doi:10.1016/S0039-6060(97)90205-1

    Article  PubMed  CAS  Google Scholar 

  37. Huang SM, Duh QY, Shaver J, Siperstein AE, Kraimps JL, Clark OH (1997) Familial hyperparathyroidism without multiple endocrine neoplasia. World J Surg 21:22–28. doi:10.1007/s002689900188

    Article  PubMed  CAS  Google Scholar 

  38. Carneiro DM, Irvin GL, Inabnet WB (2002) Limited versus radical parathyroidectomy in familial isolated primary hyperparathyroidism. Surgery 132:1050–1054. doi:10.1067/msy.2002.128695

    Article  PubMed  Google Scholar 

  39. Evans DB, Rich TA, Cote GJ (2007) Surgical management of familial hyperparathyroidism. Ann Surg Oncol 14:1525–1527. doi:10.1245/s10434-006-9282-7

    Article  PubMed  Google Scholar 

  40. Simonds WF, James-Newton LA, Agarwal SK et al (2002) Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 81:1–26. doi:10.1097/00005792-200201000-00001

    Article  Google Scholar 

Download references

Acknowledgments

We thank the families that graciously agreed to participate in the study. The study was supported by a grant from University of Padua (no. 60A07-5808/09) to Maurizio Iacobone and by a grant from Istituto Superiore di Sanità (no. 526D/40).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maurizio Iacobone.

Additional information

Best of Endocrine Surgery in Europe 2009

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iacobone, M., Masi, G., Barzon, L. et al. Hyperparathyroidism–jaw tumor syndrome: a report of three large kindred. Langenbecks Arch Surg 394, 817–825 (2009). https://doi.org/10.1007/s00423-009-0511-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-009-0511-y

Keywords

Navigation